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Abstract
Background: Regulatory T cells are central actors in the maintenance of tolerance of self-antigens or allergens and in the
regulation of the intensity of the immune response during infections by pathogens. An understanding of the network of the
interaction between regulatory T cells, antigen presenting cells and effector T cells is starting to emerge. Dynamical systems
analysis can help to understand the dynamical properties of an interaction network and can shed light on the different tasks
that can be accomplished by a network.
Methodology and Principal Findings: We used a mathematical model to describe a interaction network of adaptive
regulatory T cells, in which mature precursor T cells may differentiate into either adaptive regulatory T cells or effector T
cells, depending on the activation state of the cell by which the antigen was presented. Using an equilibrium analysis of the
mathematical model we show that, for some parameters, the network has two stable equilibrium states: one in which
effector T cells are strongly regulated by regulatory T cells and another in which effector T cells are not regulated because
the regulatory T cell population is vanishingly small. We then simulate different types of perturbations, such as the
introduction of an antigen into a virgin system, and look at the state into which the system falls. We find that whether or not
the interaction network switches from the regulated (tolerant) state to the unregulated state depends on the strength of
the antigenic stimulus and the state from which the network has been perturbed.
Conclusion/Significance: Our findings suggest that the interaction network studied in this paper plays an essential part in
generating and maintaining tolerance against allergens and self-antigens.
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Introduction
Developing an adequate immune response against antigens is
vital for all animal species. To respond adequately, an immune
system must discriminate harmful foreign pathogens from
beneficial microbes and self-antigens. An important player in
balancing benefits and costs of immune responses are regulatory T
cells. They are involved in the control of auto-immunity, the
induction of tolerance to foreign antigens, but also in limiting
immunopathology during both acute and chronic infections.
The past decade has seen the large expansion of the character-
ization of regulatory T cells [1] and their classification into distinct
subsets. The two main types of regulatory T cells are the so-called
natural and adaptive regulatory T cells [2,3]. While natural
regulatory T cells are produced by the thymus and are committed
suppressors of immunity from the beginning of their life [4], adaptive
regulatory T cells can be induced in the periphery from precursor T
cells [5,6] that could otherwise turn into effector cells.
How adaptive regulatory T cells are regulated is still under
debate, but experimental evidence converges toward some
important features. The interaction network proposed by Powrie
and Maloy [7] (represented schematically in Fig. 1) summarizes
one route by which adaptive regulatory T cells can be induced.
The differentiation of mature T cells into effector cells requires
the presentation of the antigen by antigen presenting cells (APC)
presenting the appropriate co-stimulatory signals [8,9], such as a
high level of expression of the B7 co-receptors (CD80 and CD86).
Without the appropriate cosignal, T cells will differentiate into
regulatory T cells [10–12]. This dichotomy is illustrated by the
experiments conducted by Jonuleit et al. [13], who stimulated
naive, allogeneic CD4(+) T cells with immature CD83(2) and
mature CD83(+) human dendritic cells (DC, a class of professional
APCs). They showed mature DCs induced inflammatory Th1 cells
whereas immature DCs induced IL-10-producing T cell regula-
tory 1-like.
In return, each T cell type will promote the activation of APCs in
a way that favors its production. Effector cells favors the activation
of DCs through the CD40-CD40L interaction [14]. Conversely,
several experiments have shown that DCs treated with IL-10, a
cytokine secreted by regulatory T cells such as type 1 regulatory T
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CD4(+) cells into IL-10 producing regulatory T cells [15–17]. The
last important actor is the antigen that activates the APCs, either
directly, via Toll-like receptors of the APC, or indirectly, by
triggering the secretion of pro-inflammatory cytokines.
Regulatory T cells ensure several different functions. They are
involved in the control of auto-immunity as well as in the
regulation of both acute and chronic infections. It would be
surprising that one interaction network alone could ensure all
these functions. Using a mathematical model, we study how the
immune system responds to different degrees of antigenic
stimulation. Our results suggest that the induction of regulatory
T cells by resting APCs may play an important role in the
prevention of auto-immune diseases.
Methods
The mathematical model is based on the interaction network
proposed by Powrie and Maloy [7] (see Fig. 1). Two cell lineages
are represented: Antigen Presenting Cells (APC, e.g. Dendritic
Cells) and CD4+ lymphocyte T cells. We define as A0 the APCs
that have not captured the antigen, as resting (A1) the APCs that
have captured the antigen and that induce precursor cells to
differentiate into regulatory T cells upon contact and as activated
(A2) the APCs that have captured the antigen and that induce
precursor cells to differentiate into effector cells upon contact. T
cells are ranged into three classes: precursor (Tp, i.e. mature but
not yet activated by the APC), effector (Te, i.e. cells that will
control the pathogen spread) and regulatory T cells (Tr).
The antigen is denoted by X. It can be e.g. a pathogen agent, a
self-peptide or an allergen. Different antigens have different
dynamics, and here we use an overly simplified one. Antigens are
produced with a constant rate pX, die with a rate mX and are killed
by effector cells with a rate k.
Resting APCs are produced with a constant rate pA and die with
a rate mA. They capture the antigen with a rate tap, called the
antigenic stimulation. To simplify we assume that antigens induce
the activation of the APCs with the same rate. Effector cells also
induce APC activation with a rate tae. Activation is reversed by
regulatory T cells activity with a rate tr.
We assume a constant influx (pP) of precursor T cells from the
thymus. Then, depending on the first APC that the cell will meet,
Figure 1. Interaction network of the immune response. Solid arrows describe the evolution of the different cell types (APCs or lymphocyte T
CD4+ cells). Dashed arrows indicate the cell types involved in the changes (for example regulatory T cells are involved in the inhibition of effector T
cells). The mathematical model developed in this paper is based on this interaction network. Rates of the mathematical model are recalled under the
evolution arrows. To make it clearer, we omitted the death of all cell types in the Figure. The antigen X is not represented here. Note that in the model
proposed by Powrie and Maloy (2003), the activity of activated APCs can revert the inhibition of effector T cells by regulatory T cells. For the sake of
simplicity, we omitted this interaction here. This does not deeply affect the qualitative nature of the results (results not shown).
doi:10.1371/journal.pone.0002306.g001
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simplify, we assume that all APCs are equally ‘‘attractive’’, i.e. the
rate of differentiation of precursor cells (w) per APC is the same
whatever the level of activation of the APC. Effector cells are
inhibited by regulatory T cells with a rate lr. We call mp the
mortality rate of precursor cells. Effector and regulatory T cells
have more complex dynamics. They can divide or die depending
on the cytokines they receive. Modeling these complex dynamic is
not the purpose here, so to simplify we just assume that the effector
and regulatory T cells populations decline with given rates called
turnover rates (respectively me and mr) in absence of newly
differentiated precursor cells. In the equilibrium, and in absence of
inhibition of effector T cells by regulatory T cells, this assumption
leads to a number of effector and regulatory T cells that are
proportional to the frequency of activated and resting APCs,
respectively. The model then reads:
dX
dt
~pX{mXX{kTeX
dA0
dt
~pA{tapXA0{mAA0
dA1
dt
~tapXA0ztrTrA2{ taeTeztapX

A1{mAA1
dA2
dt
~{trTrA2z taeTeztapX

A1{mAA2
dTp
dt
~pP{mpTp{wA2Tp{wA1Tp
dTe
dt
~wA2Tp{meTe{lrTrTe
dTr
dt
~wA1Tp{mrTr
Note that in the interaction network proposed by Powrie and
Maloy [7], activated APCs may revert the inhibitory effect of
regulatory T cells on effector T cells [18]. For the sake of
simplicity, we did not include this phenomenon here.
The model being too complex to be treated analytically, we use
numerical simulations to estimate the dynamic of the system and
its equilibria. This requires to estimate the value of the parameters.
Determining accurate values is unfortunately impossible. First, the
model does not focus on a specific species. Many parameters differ
between species and so have no standard value. Second, many
parameters are difficult to determine. For example, if it is clear
that regulatory T cells may revert the activation of APCs, it is not
known how much regulatory T cells are required for the reversion
of one APC.
The approach we use here consists in scanning vast ranges of
possible parameters and investigating the dynamical properties of
the system. We are confident that we did not miss any dynamical
behavior the model can display. This strategy of scanning
parameter space is a more comprehensive way to look at a
dynamical system that a strategy based on plausible parameter-
ization. To sum up we focus on the dynamics and generic
principles involved in the regulation of the immune response,
rather than on a numerically accurate description of such systems.
Basic values of the parameters are given in Table 1. In the
present paper we only show the impact of the most significative
ones. Basic parameters are chosen according to the following rules.
The antigens and APCs are normalized: their maximum value is
one. This is obtained by setting their production rate equal to they
death rate. In optimal condition, where all APCs are activated and
regulatory T cells are depleted, 99% of the antigen is depleted. We
assume that one antigen is produced (or introduced) per day, but
this value is not critical since most of the study focuses on the
equilibrium.
In absence of antigen, hundred precursor cells (that show the
specificity of the antigen) pre-exist. They have a 1% turnover per
day. We assume that when all APCs have captured the antigen,
99% of the precursor cells have differentiated (into effector cells or
regulatory T cells).
The maximum number of regulatory T cells (i.e. when all APCs
are resting) is amongst the parameters that are difficult to estimate.
This is due to the wide variety of regulatory T cells, the lack of
simple markers for adaptive regulatory T cells and the fact that the
number of regulatory T cells that are observed in experiments also
depends on the fraction of APCs that are resting. In fact, we do
have to determine this parameter here. One can easily show that
reducing the maximal number of regulatory T cells can be easily
compensated by increasing the impact each regulatory T cells
have on other cells types, through the formulas that are given in
Table 1. The same principle applies to effector T cells.
Finally the turnover rates (me and mr) are also among the
parameters that are complex to estimate. In our model, these
parameters do not just denote the death rates of effector and
regulatory cells, but indirectly also their proliferation rates (more
precisely the time required for a cell population to reach its
equilibrium value is decreasing with its turnover rate). Thus, these
parameters denote the turnover rates of effector and regulatory
Table 1. Basic value of the parameters (time unit is the day).
Parameter Symbol Relation
Basic
value
Reproduction rate of the antigen pX 1
Death rate of the antigen mX 1
Birth rate of precursor cells pP 1
Mortality rate of precursor cells mp 10
22
Rate of effector T cells decay me 0.1
Rate of regulatory T cells decay mr 0.1
Birth rate of APCs pA 0.2
Death rate of APCs mA 0.2
Maximum number of effector T cells Te
max pP
me
10
Maximum number of regulatory T cells Tr
max pP
mr
10
Rate of pathogen killing by effector cells k k0
Tmax
e
k
0=10
2
Rate of APC activation by the antigen tap variable
Rate of APC reactivation by effector cells tae t0
ae
Tmax
e
variable
Rate of differentiation of precursor cells
by APCs
w 1
Rate of inhibition of effector T cell by
regulatory T cells
lr l
0
r
Tmax
r Tmax
e
variable
Rate of APC inhibition by regulatory T cellstr t0
r
Tmax
r
variable
doi:10.1371/journal.pone.0002306.t001
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particular it means there is around 10 days between the
introduction of the antigen and the peak in the effector T cell
response. Regulatory and effector T cells turnover rates have no
impact here on the equilibrium states. This is due to the
compensation rules showed in Table 1.
Results
A) Equilibrium analysis
The dynamical system tends to extreme: strong or weak
regulation. To investigate the role of regulatory T cells in
balancing the benefits and costs of immune responses against
chronic infection, allergens and self-antigens, we performed an
equilibrium analysis of the population dynamical system described
in the Method section and Fig. 1. An equilibrium analysis allows
us to study the long-term behavior of population dynamical
systems.
The particular antagonistic nature of the interaction between
regulatory and effector T cells in the model leads effectively to the
competitive exclusion of effectors or regulatory T cells. The reason
for this is that more regulatory T cells leads to more resting APCs,
and finally to more regulatory T cells. Similarly, more effector cells
lead to more activated APCs and thus to more effector cells. In
such dynamical systems, one of the cell types will outcompete the
other. This lead to either a state of weak regulation, in which
effector T cells are abundant and the levels of regulatory T cells
are very low, or to a strongly regulated state, in which effector cells
are strongly repressed by regulatory cells. The suppression of one
cell type by the other never leads to extinction because resting
APCs are constantly produced by the capture of the antigen and
activated APCs are constantly produced by antigenic stimulation.
In the strongly regulated state, the number of effector cells is much
lower than the level of effector cells in the weakly regulated state
(Fig. 2). However, highly stimulating antigens can revert the
suppression of effector cells. In any case, highly stimulating
antigens always lead to a weakly regulated state (see Fig. 2). The
nature of the state in which the system falls has direct
consequences on the antigen. In the strongly regulated state the
antigen is almost not suppressed by the immune system whereas in
the weakly regulated the strong immune response that is mounted
leads to a large reduction in the antigen level (results not shown).
We find that there are three parameter regimes:
1) Regime 1 in which there is only a strongly regulated state
(Fig. 2a),
2) Regime 2 in which there is only a weakly regulated state
(Fig. 2b), and
Figure 2. Equilibrium states of the system. Number of effector (bold lines) and regulatory (thin lines) cells in the equilibrium states according to
the antigenic stimulation (tap), in: (a) an example of situation with only one stable and strongly regulated equilibrium (tae
0=10
2); (b) an example of
situation with only one stable and weakly regulated equilibrium (tae
0=10
6) and (c) an example of bi-stable situation with an unstable equilibrium in
between (tae
0=10
4). To distinguish between the two equilibrium states, the strongly regulated one is plotted with dashed lines. Note also that only
stable states are presented here. In the bistable regime there is always another equilibrium state that is unstable. lr
0=10
4, tr
0=10 in all the situations.
doi:10.1371/journal.pone.0002306.g002
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can be attained (Fig. 2c).
Conditions for bi-stability. We investigated the boundaries
between these three parameter regimes. In the following analysis,
we focus on three parameters: tr
0, lr
0 and tae
0. The first two rate
constants describe the effect of regulatory T cells on APCs and
effector T cells, respectively, and tae
0 describes the effect of effector
T cells on APCs. These rate constants are at the center of the
regulatory network that our model describes (see Fig. 1).
Regime 1 is characterized by a large impact of regulatory T cells
(either on APCs or on effector cells) or a small impact of effector
cells on APCs, while Regime 2 is characterized by a small impact
of regulatory T cells and a large impact of effector cells. Regime 1
and 2 are separated by Regime 3.
Regime 3 in which bistability occurs becomes larger if the
maximum inhibitory effect of regulatory T cells on APC activation
state increases (parameter tr
0) (Fig. 3a). The size of the bistability
region depends on how resting APC arise. The bistability region is
large if resting APCs arise more frequently by de-activation of
resting APCs by regulatory T cells (tr
0) than by naı ¨ve APCs that
capture the pathogen (tapX). If regulatory T cells do not affect
activated APCs bi-stability is not predicted by our model.
Fig. 3b–d show how the bistability region depends on the lr
0
and tae
0, i.e. the rates constants describing the inhibition of effector
T cells by regulatory T cells and APC activation induced by
effector T cells. For tae
0/lr
0 approximately 1, the system displays
bistability, i.e. bistability is the result of the right balance between
the extent to which effector T cells are inhibited versus their
effectiveness. If regulatory T cells do not inhibit effector T cells, bi-
stability is not predicted by our model.
B) Responding or not responding?
Any immune system has to be able to tolerate certain stimuli,
while responding to other, such as pathogens. In the third
parameter regime, in which both, stronlgy and weakly regulated
states, can be attained, our model displays a dynamical behavior
that enables the host’s immune system to prevent autoimmunity
while still allowing for effective responses against pathogens.
Attaining the strongly regulated state corresponds to the immune
system’s tolerance to a given antigenic stimulus, while attaining the
weakly regulated state corresponds to mounting a strong immune
response against an antigen. Experimental data on adoptive
transfer of tolerance suggest the existence of such a bi-stability
(reviewed in [19]).
We investigated into which state — the strongly or the weakly
regulated — the immune system described by our model falls in
response to different antigenic stimuli, such as pathogens,
allergens, or self-antigens. Obviously, a well-designed immune
Figure 3. Impact of the parameters on the nature of the equilibrium regime. Situations are divided into the 3 regimes described in the main
text (see also Fig. 2). (a) For different values of the activation rate of APCs by effector cells (tae
0) and different rates of regression of APCs by regulatory
T cells (tr
0), with lr
0=10
4; (b) for different values of the activation rate of APCs by effector T cells (tae
0) and different rates of inhibition of effector cells
by regulatory T cells (lr
0), with tr
0=1; (c) same as (b) but with tr
0=10; (d) same as (b) but with tr
0=0.1.
doi:10.1371/journal.pone.0002306.g003
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antigens, while mounting an immune response against pathogens.
We simulated the response against antigens in two different
ways: by perturbing the system from a virgin state, in which there
are only naı ¨ve APCs and precursor T cells, or from the strongly
regulated (tolerant) state. The virgin state was perturbed by
introducing a certain number of antigens, X
0, which roughly
corresponds to the introduction of a pathogen or an allergen that
the immune system has not encountered before. The hyper-
regulated state, on the other hand, was perturbed by an
‘‘inflammatory burst’’ (a short, but intensive upregulation of
APC activation), which roughly corresponds to a spontaneous
immune reaction against a self-antigen. We then examine how the
immune system reacts to these perturbations, i.e. into which
equilibrium state the system falls after the perturbation, and how
its reaction depends on key parameters of the regulatory system.
Factors leading to strong primary immune responses.
To investigate potential primary immune responses, we perturb
an immune system from its virgin state. The relative growth rate
of regulatory and effector T cells determines into which state the
system falls after perturbation. Due to model assumptions, the
growth rate of the effector and regulatory T cell population is
inversely proportional to their turnover rates me and mr,
respectively. In Fig. 4a, we show into which state the immune
system falls as a function of me and mr. We find that the state into
which the immune system falls after perturbation is more
sensitive to changes in mr than to changes in me. This is intuitive
because regulatory T cells are the only force leading to de-
activation of APCs, whereas APCs are activated by effector T
cells as well as the antigen. Thus, the influence of effector T cell
turnover on the reaction of the immune system is less
pronounced.
Until now we assumed that at time t=0 no regulatory T cells is
present in the organism. With this assumption, we ignore, for
example, the potential pre-existence of natural regulatory T cells
that can exert non-specific inhibition. Many experimental studies
suggest that these natural regulatory T cells are essential in
preventing immunopathologies [1,20]. Thus, the generation of
adaptive regulatory T cells in response to an antigen is, on its own,
not sufficient to prevent an aberrant immune response.
To model the different kinds of pre-existing regulatory cells
and cytokines, we assume that at time t=0 a given number of
regulatory T cells (Tr
0) are present. Fig. 4b shows into which
state the system falls as a function of the level of pre-existing
regulatory cells, Tr
0 and their turnover rate, mr. When the
turnover rate of regulatory T cells is small (leading to a low
growth rate of the regulatory T cells population), pre-existing
regulatory T cells are necessary to maintain tolerance. The
critical number of pre-existing regulatory T cells required for
tolerance increases with the time required to put the adaptive
regulatory response in place (i.e. decreases with mr). There is a
threshold value of the turnover rate of regulatory cells beyond
which pre-existing regulatory cells are not needed for tolerance
(at approximately 0.2 in Fig. 4b).
Short-term inflammation helps to trigger a long lasting
immune response. Another important factor for the long-term
Figure 4. Factors leading to strong primary immune responses. Values of the parameters are as in Fig. 2c (basic: tae
0=10
4, lr
0=10
4, tr
0=10
and see Table 1) so that we are in the bi-stability region (regime 3). Initially, there are no effector T cells. At time t=0, one (i.e. the maximum quantity)
antigen is introduced (X
0=1): we neglect the growing phase of the antigen. Grey zones correspond to tolerance, i.e. the system falls into the strongly
regulated state. White zones correspond to the development of a strong immune response, i.e. the system falls into the weakly regulated state. (a)
Effect of the the effector and regulatory T cells turnover rates (me and mr, respectively), with tap=10
22; (b) effect of the pre-existing number of
regulatory T cells (Tr
0) and the regulatory T cells turnover rate (mr), with tap=10
22; and (c) impact of an inflammatory burst on the development of an
immune response, depending on its duration (D) and intensity (tap
inf), with tap
rest=10
22 and Tr
0=1. Note that in Fig. 4a Tr
0=0.
doi:10.1371/journal.pone.0002306.g004
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famous example is the use of adjuvant with vaccine. By inducing
local inflammation, adjuvant helps developing a long lasting
immune response. Here we model inflammation by assuming that,
after the introduction of the pathogen, there is a period of time
during which the activation rate of APCs by the antigen is larger.
Once the inflammation period is finished the activation rate of
APCs by the antigen comes back to its normal level. We denote
the duration of the inflammation period by D, and the antigen-
induced activation rate during and after the inflammation as tinf
ap
and trest
ap , respectively. We observe that the system falls into a
weakly regulated state for high tinf
ap or high D, i.e. a strong immune
response is mounted after either strong or long inflammatory
episodes (Fig. 4c).
Overcoming strong regulation of an immune response
against persistent antigens (e.g. autommunity) requires a
longer inflammation. Now, we focus on persistent antigens,
e.g. self-antigens that may continuously stimulate the immune
system. We assume that the immune response against the
persistent antigen is in the strongly regulated state (unlike for
introduced antigens for which we assumed the immune system to
be in a virgin state). At time t=0, we then perturb the system by
simulating an inflammatory episode as above.
We estimate the minimum duration of inflammation required to
bring the immune system into the weakly regulated state, i.e. to
trigger a strong long-lasting immune response. Qualitatively, our
results are similar to those found for introduced antigens. We find
the same negative relationship between the intensity of the
stimulation and the minimal duration of inflammation (Fig. 5a).
Interestingly tolerance is more easily achieved than for introduced
antigens. In other words, chronic exposition to antigens increases
the number of regulatory cells and cytokines, making tolerance
harder to break.
Finally, breaking tolerance once the strongly regulated equilib-
rium is established requires clearing the regulatory T cell
population. Unsurprisingly, large turnover rates of regulatory T
cells favor the establishment of a long lasting immune response
(Fig. 5b).
Discussion
The purpose of an immune system is the defense against
pathogens. A well-designed immune system, however, will require
safe-guards against immune responses that are misdirected (e.g.
directed against non-pathogenic antigens or self-antigens) or too
strong. Experimental immunology deals with characterizing the
players of the immune system (including the safe-guard mecha-
nisms) and their molecular and cellular interactions. In addition to
the characterization of the players and their interactions, however,
understanding the function of an immune system requires an
analysis of the dynamical properties of the interaction networks.
Viewing the immune system as a dynamical system, one can
derive some desired properties a priori. For example, an immune
system should have multiple stable states, such as a state of
responsiveness, or a state of tolerance against an antigen.
Experiments on adoptive transfer of tolerance [1,21–24] show
the bistable nature of the immune system. The experiments consist
in the transfer of T cells from donors that are either tolerant or
responsive to some antigens. Depending on the quantity and
nature of the cells transferred, the recipient may mount an
immune response or become tolerant. Dynamical systems analysis
then allows us to investigate when certain states are attained and
under which circumstances states are changed.
In this paper, we analyzed the dynamical properties of an
interaction network between adaptive regulatory T cells and
antigen presenting cells proposed by Powrie and Maloy [7]. We
find that, for some parameters, the dynamical system representing
that interaction network has two stable equilibria.
Such a bistable dynamic can be obtained with regulatory T cells
through diverse interaction networks [19,25], for example the
cross-regulation model (reviewed in [26]). The cross-regulation
model describes the interaction between natural regulatory T cell,
the effector cell they suppress and APCs. One fundamental
assumption for the occurence of bi-stabe dynamics in that model is
that the growth of the natural regulatory T cells population
depends on the interaction with effector cells they suppress. It is
interesting to note that our model also displays the existence of two
Figure 5. Stability of the strongly regulated equilibrium. It is characterized by the mean period of time (D) during which inflammation must
be maintained to induce a long lasting immune response. Again values of the parameters are as in Fig. 2c (basic: tae
0=10
4, lr
0=10
4, tr
0=10 and see
Table 1). (a) Effect of the duration (D) and intensity (tap
inf) of the inflammatory burst. The threshold line obtained with the same parameters but for an
introduced antigen is reported on the graph as a dashed line (with Tr
0=1, see Fig. 4d); and (b) Effect of the duration of the inflammatory burst (D) and
the regulatory T cells turnover rate (mr), with tap
inf=10
3. As in Fig. 4 grey zones correspond to tolerance and white zones correspond to the
development of a strong immune response. In (a) and (b), tap
rest=10
22.
doi:10.1371/journal.pone.0002306.g005
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interaction of different cell types and mechanisms. As a
consequence, our interpretation of the significance of the
bistability is similar.
Similarly to the cross-regulation model, our model is consistent
with empirical evidence (see [26] for a full review of the
consistency between the cross-regulation model and empirical
evidence). Our model is consistent with experiments about
adoptive transfer of tolerance, which reveal the importance of
the initial balance between regulatory and effector T cells. Another
feature of our model is that regular exposition to tolerated antigens
stimulates the production of adaptive regulatory T cells and thus
maintains the system in a more tolerant state. This can explain
why repeated exposure to self-antigens are necessary to maintain
self-tolerance [27].
As the cross-regulation model [26], the model also yields a dual
role of repeated exposition to pathogenic antigens: they can induce
as well as break tolerance. Repeated exposition to benign and
tolerated pathogens leads to the production of regulatory T cells,
which helps to maintain tolerance. This improved tolerance has
also consequences for other non-cross reacting antigens, since the
production of IL-10 by adaptive regulatory T cells may exert a
bystander effect on other effector cells and renders APCs more
tolerant. The induction of tolerance by repeated exposition to
pathogens is consistent with the hygiene hypothesis [28,29],
according to which the increase in the number of allergies that has
been observed these past decades is due to the improvement of
hygiene conditions. On the other hand, non-tolerated pathogens
may cause strong local inflammation. This can lead to the
development of an immune response against other, normally
tolerated, antigens, as has been observed experimental studies [30–
32] and linked to the adjuvant effect.
Although both our model and the cross-regulation model
explain the same set of experimental observations, they also
display important differences. In the cross-regulation model one
fundamental assumption is the requirement for effector cells for
the replication of regulatory cells. Such a factor can be IL-2, which
is secreted by effector cells and is required for the growth of the
natural regulatory T cell population (see [33] for a review). The
cross-regulation model is consistent with observations in IL-2
deficient mice, which spontaneously develop autoimmunity [34].
However this is not in contradiction with our model, since in any
case preventing the growth of the natural regulatory cells reduces
the initial regulatory force, and hence can lead to autoimmunity in
our model too. Another major difference between our model and
the cross-regulation model is the role of resting APCs. Exper-
imental evidence shows that the adoptive transfer of immature
DCs results in an important increase in the number of IL-10
producing cells [17,35] and helps to resolve inflammation and
maintain tolerance [17,36], which is consistent with our model.
Hence it is possible that the cross-regulation model and the
induction of regulatory T cells by the interaction with resting
APCs are both important and complementary mechanisms for the
maintenance of tolerance.
The consistency between the model proposed here and
experimental results about tolerance suggest a potential role that
induction of regulatory T cells by resting APCs [37,38] in concert
with adaptive regulatory T cells [39–41] could play in the
prevention of autoimmunity. In fact, experimental studies show
that both natural [1,20] and adaptive [39–41] regulatory T cells
are crucial for preventing autoimmune diseases. Asseman et al.
[42] observed that natural regulatory T cells may control
inflammatory bowel disease, but that IL-10 is mandatory for the
control of the disease. Surprisingly they also observed that the
transfer of natural CD4+CD25+ regulatory T cells isolated from
IL-10-/- mice still inhibited the disease. These observations are
easily explained by our model since experiments also show that
natural regulatory T cells can induce the differentiation of
precursor T cells into IL-10 producing regulatory T cells [43]
and thus act as an initial regulatory force to maintain tolerance.
Finally, we would like to emphasize that, in our model, we make
quite strongly simplifying assumptions about the generation of the
immune response. In our model, the dynamic of both effector and
regulatory T cells are reduced to simple turnover. In fact, type 1
regulatory T cells, a class of IL-10 producing adaptive regulatory
T cells, can proliferate in response to IL-15 [44]. Effector cells also
maintain themselves by homeostatic proliferation after their
differentiation from naive/precursor cells. How tolerance is
maintained in the periphery in the long-term depends on the
homeostatic proliferation of the different cell types – effector T
cells and adaptive and natural regulatory T cells – and cannot be
addressed properly in this paper. We also neglect several
important features that arise during chronic infections: the
differentiation of effector T cells differentiate into memory cells,
the fact that continuous exposure to antigens leads to effector T
cell exhaustion [45] and differentiation into regulatory cells [46].
For these reasons, the model presented in this paper is not
appropriate to study the immune response during chronic
infections. However, despite these simplifying assumptions regard-
ing the immune response, we can use this model to investigate the
early immune response and in particular if, in response to a
perturbation, an immune response will be mounted or not. In the
model, convergence is rather fast (basically it is of the order of
magnitude of the inverse of the turnover rates), so the equilibrium
in which the system falls gives a good idea of how the system
behaves in the few weeks that follow the perturbation.
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